CPhI: Aesica to triple API sales in three years, to acquire assets in North America and India next year
14:18 PM | October 11, 2012 | Deepti Ramesh in Madrid
Aesica Pharmaceuticals (Newcastle, UK), a provider of active pharmaceutical ingredients (APIs), formulations, and custom synthesis, says that it plans to triple annual revenues from the company’s API...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.